Koers Kamada Ltd. TEL AVIV STOCK EXCHANGE
Aandelen
IL0010941198
Farmaceutische producten
Omzet 2024 * | 587 mln. 158 mln. 58,74 mld. 146 mln. | Omzet 2025 * | 664 mln. 179 mln. 66,43 mld. 165 mln. | Marktkapitalisatie | 1,15 mld. 310 mln. 115 mld. 285 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 55 mln. 14,83 mln. 5,5 mld. 13,64 mln. | Nettowinst (verlies) 2025 * | 66 mln. 17,79 mln. 6,6 mld. 16,36 mln. | EV/omzet 2024 * | 1,96 x |
Nettoliquiditeiten 2024 * | - 0 0 0 | Nettoliquiditeiten 2025 * | - 0 0 0 | EV/omzet 2025 * | 1,73 x |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 54,25% |
Recentste transcriptie over Kamada Ltd.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Amir London
CEO | Chief Executive Officer | 55 | 09-12-13 |
David Tsur
FOU | Founder | 73 | 13-12-90 |
Chaime Orlev
DFI | Director of Finance/CFO | 53 | 31-12-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | 24-12-19 |
Leon Recanati
BRD | Director/Board Member | 76 | 01-05-05 |
David Tsur
FOU | Founder | 73 | 13-12-90 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,32% | 92,59 mld. | |
+3,16% | 41,43 mld. | |
-11,10% | 33,49 mld. | |
-20,19% | 14,62 mld. | |
-9,41% | 12,77 mld. | |
-12,25% | 11,58 mld. | |
-44,00% | 11,35 mld. | |
+4,57% | 8,97 mld. | |
-6,32% | 8,3 mld. |